- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x SAM: S-ADENOSYLMETHIONINE(Non-covalent)
- 4 x B0L: 4-hydroxy-3-[(2S,6E,8E)-2-methyldeca-6,8-dienoyl]-5-phenylpyridin-2(1H)-one(Non-covalent)
B0L.2: 17 residues within 4Å:- Chain A: G.148, H.151, L.156, C.193, F.207, L.210, D.213, R.313, D.314, T.356, C.359, I.360, A.363, L.364
- Chain B: F.59, S.66
- Ligands: EDO.11
12 PLIP interactions:11 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:L.156, A:L.156, A:F.207, A:L.210, A:I.360, A:A.363, B:F.59
- Hydrogen bonds: A:H.151, A:R.313, A:D.314
- Water bridges: A:T.356
- pi-Stacking: A:H.151
B0L.21: 20 residues within 4Å:- Chain A: F.59, V.62, M.63
- Chain B: L.145, G.148, H.151, L.156, C.193, L.197, F.207, L.210, D.213, R.313, D.314, T.356, C.359, I.360, A.363, L.364
- Ligands: EDO.27
18 PLIP interactions:15 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:L.145, B:L.156, B:L.156, B:L.197, B:F.207, B:L.210, B:I.360, B:A.363, A:F.59, A:F.59, A:V.62
- Hydrogen bonds: B:H.151, B:D.314
- Water bridges: B:R.313, B:R.313, B:R.313, B:R.313
- pi-Stacking: B:H.151
B0L.34: 17 residues within 4Å:- Chain C: G.148, H.151, L.156, C.193, F.207, L.210, D.213, R.313, D.314, T.356, C.359, I.360, A.363, L.364
- Chain D: F.59, S.66
- Ligands: EDO.43
11 PLIP interactions:10 interactions with chain C, 1 interactions with chain D- Hydrophobic interactions: C:L.156, C:L.156, C:F.207, C:L.210, C:I.360, C:A.363, D:F.59
- Hydrogen bonds: C:H.151, C:R.313, C:D.314
- pi-Stacking: C:H.151
B0L.53: 20 residues within 4Å:- Chain C: F.59, V.62, M.63
- Chain D: L.145, G.148, H.151, L.156, C.193, L.197, F.207, L.210, D.213, R.313, D.314, T.356, C.359, I.360, A.363, L.364
- Ligands: EDO.59
18 PLIP interactions:15 interactions with chain D, 3 interactions with chain C- Hydrophobic interactions: D:L.145, D:L.156, D:L.156, D:L.197, D:F.207, D:L.210, D:I.360, D:A.363, C:F.59, C:F.59, C:V.62
- Hydrogen bonds: D:H.151, D:D.314
- Water bridges: D:R.313, D:R.313, D:R.313, D:T.356
- pi-Stacking: D:H.151
- 32 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 8 residues within 4Å:- Chain A: E.108, L.109, R.112
- Chain B: P.173, D.174, I.175, V.176, M.361
Ligand excluded by PLIPEDO.4: 3 residues within 4Å:- Chain A: K.227, E.228, R.336
Ligand excluded by PLIPEDO.5: 7 residues within 4Å:- Chain A: P.173, D.174, I.175, M.361
- Chain B: E.108, L.109, R.112
Ligand excluded by PLIPEDO.6: 4 residues within 4Å:- Chain A: S.133, S.134, N.135, Q.138
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain A: T.212, D.213, E.214
Ligand excluded by PLIPEDO.8: 2 residues within 4Å:- Chain A: P.201, T.202
Ligand excluded by PLIPEDO.9: 6 residues within 4Å:- Chain A: Q.301, G.302, P.329, A.330, M.331, D.332
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain A: L.275, Q.276, Q.279, S.289
Ligand excluded by PLIPEDO.11: 3 residues within 4Å:- Chain A: H.151, L.210
- Ligands: B0L.2
Ligand excluded by PLIPEDO.22: 3 residues within 4Å:- Chain B: K.85, A.141, P.143
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain B: S.133, S.134, N.135, Q.138
Ligand excluded by PLIPEDO.24: 2 residues within 4Å:- Chain B: I.204, K.208
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain B: T.392, W.393, P.394, V.395, N.397
Ligand excluded by PLIPEDO.26: 6 residues within 4Å:- Chain B: I.175, V.176, P.316, D.317, G.365, K.367
Ligand excluded by PLIPEDO.27: 3 residues within 4Å:- Chain B: H.151, L.210
- Ligands: B0L.21
Ligand excluded by PLIPEDO.28: 4 residues within 4Å:- Chain A: P.58
- Chain B: N.135, Q.138, T.139
Ligand excluded by PLIPEDO.35: 8 residues within 4Å:- Chain C: E.108, L.109, R.112
- Chain D: P.173, D.174, I.175, V.176, M.361
Ligand excluded by PLIPEDO.36: 3 residues within 4Å:- Chain C: K.227, E.228, R.336
Ligand excluded by PLIPEDO.37: 7 residues within 4Å:- Chain C: P.173, D.174, I.175, M.361
- Chain D: E.108, L.109, R.112
Ligand excluded by PLIPEDO.38: 4 residues within 4Å:- Chain C: S.133, S.134, N.135, Q.138
Ligand excluded by PLIPEDO.39: 3 residues within 4Å:- Chain C: T.212, D.213, E.214
Ligand excluded by PLIPEDO.40: 2 residues within 4Å:- Chain C: P.201, T.202
Ligand excluded by PLIPEDO.41: 6 residues within 4Å:- Chain C: Q.301, G.302, P.329, A.330, M.331, D.332
Ligand excluded by PLIPEDO.42: 4 residues within 4Å:- Chain C: L.275, Q.276, Q.279, S.289
Ligand excluded by PLIPEDO.43: 3 residues within 4Å:- Chain C: H.151, L.210
- Ligands: B0L.34
Ligand excluded by PLIPEDO.54: 3 residues within 4Å:- Chain D: K.85, A.141, P.143
Ligand excluded by PLIPEDO.55: 4 residues within 4Å:- Chain D: S.133, S.134, N.135, Q.138
Ligand excluded by PLIPEDO.56: 2 residues within 4Å:- Chain D: I.204, K.208
Ligand excluded by PLIPEDO.57: 5 residues within 4Å:- Chain D: T.392, W.393, P.394, V.395, N.397
Ligand excluded by PLIPEDO.58: 6 residues within 4Å:- Chain D: I.175, V.176, P.316, D.317, G.365, K.367
Ligand excluded by PLIPEDO.59: 3 residues within 4Å:- Chain D: H.151, L.210
- Ligands: B0L.53
Ligand excluded by PLIPEDO.60: 4 residues within 4Å:- Chain C: P.58
- Chain D: N.135, Q.138, T.139
Ligand excluded by PLIP- 16 x CL: CHLORIDE ION(Non-functional Binders)
CL.12: 5 residues within 4Å:- Chain A: K.347, G.348, A.349
- Chain B: R.115, Q.125
Ligand excluded by PLIPCL.13: 4 residues within 4Å:- Chain A: Y.259, P.260, N.261, Q.262
Ligand excluded by PLIPCL.14: 1 residues within 4Å:- Chain A: R.150
Ligand excluded by PLIPCL.15: 3 residues within 4Å:- Chain A: R.215, T.216
- Chain B: F.59
Ligand excluded by PLIPCL.16: 3 residues within 4Å:- Chain A: M.161, A.162, K.185
Ligand excluded by PLIPCL.29: 3 residues within 4Å:- Chain B: S.221, T.222, F.223
Ligand excluded by PLIPCL.30: 2 residues within 4Å:- Chain B: S.79, R.150
Ligand excluded by PLIPCL.31: 3 residues within 4Å:- Chain B: D.80, L.81, G.82
Ligand excluded by PLIPCL.44: 5 residues within 4Å:- Chain C: K.347, G.348, A.349
- Chain D: R.115, Q.125
Ligand excluded by PLIPCL.45: 4 residues within 4Å:- Chain C: Y.259, P.260, N.261, Q.262
Ligand excluded by PLIPCL.46: 1 residues within 4Å:- Chain C: R.150
Ligand excluded by PLIPCL.47: 3 residues within 4Å:- Chain C: R.215, T.216
- Chain D: F.59
Ligand excluded by PLIPCL.48: 3 residues within 4Å:- Chain C: M.161, A.162, K.185
Ligand excluded by PLIPCL.61: 3 residues within 4Å:- Chain D: S.221, T.222, F.223
Ligand excluded by PLIPCL.62: 2 residues within 4Å:- Chain D: S.79, R.150
Ligand excluded by PLIPCL.63: 3 residues within 4Å:- Chain D: D.80, L.81, G.82
Ligand excluded by PLIP- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.17: 6 residues within 4Å:- Chain A: S.54, L.55, E.56, T.57, P.58
- Chain B: R.41
5 PLIP interactions:4 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:R.41
- Water bridges: B:R.41, B:R.41, B:N.135, A:E.56
GOL.49: 6 residues within 4Å:- Chain C: S.54, L.55, E.56, T.57, P.58
- Chain D: R.41
5 PLIP interactions:1 interactions with chain C, 4 interactions with chain D- Water bridges: C:E.56, D:R.41, D:R.41, D:N.135
- Hydrogen bonds: D:R.41
- 4 x NA: SODIUM ION(Non-functional Binders)
NA.18: 2 residues within 4Å:- Chain A: P.316, D.317
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.317, A:D.317
NA.32: 3 residues within 4Å:- Chain B: S.95, A.96, E.97
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.95, B:A.96, B:E.97
NA.50: 2 residues within 4Å:- Chain C: P.316, D.317
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:D.317, C:D.317
NA.64: 3 residues within 4Å:- Chain D: S.95, A.96, E.97
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:S.95, D:A.96, D:E.97
- 2 x IMD: IMIDAZOLE(Non-covalent)
IMD.19: 7 residues within 4Å:- Chain A: L.220, S.221, T.222, F.223, P.224, K.258, Y.259
2 PLIP interactions:2 interactions with chain A- Water bridges: A:L.225, A:Y.259
IMD.51: 7 residues within 4Å:- Chain C: L.220, S.221, T.222, F.223, P.224, K.258, Y.259
1 PLIP interactions:1 interactions with chain C- Water bridges: C:L.225
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cai, Y. et al., Structural basis for stereoselective dehydration and hydrogen-bonding catalysis by the SAM-dependent pericyclase LepI. Nat.Chem. (2019)
- Release Date
- 2019-07-17
- Peptides
- O-methyltransferase lepI: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x SAM: S-ADENOSYLMETHIONINE(Non-covalent)
- 4 x B0L: 4-hydroxy-3-[(2S,6E,8E)-2-methyldeca-6,8-dienoyl]-5-phenylpyridin-2(1H)-one(Non-covalent)
- 32 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 16 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- 4 x NA: SODIUM ION(Non-functional Binders)
- 2 x IMD: IMIDAZOLE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cai, Y. et al., Structural basis for stereoselective dehydration and hydrogen-bonding catalysis by the SAM-dependent pericyclase LepI. Nat.Chem. (2019)
- Release Date
- 2019-07-17
- Peptides
- O-methyltransferase lepI: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B